Trial Profile
Phase II study of M118103 in the treatment of nodular prurigo which does not respond to topical steroid treatment
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs M-118103 (Primary) ; Diflorasone
- Indications Prurigo nodularis
- Focus Therapeutic Use
- Sponsors Maruho
- 07 Mar 2018 New trial record